Erosive Gastroesophageal Reflux DiseasePULSNCT00562094
Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS)
An observational study of Erosive Gastroesophageal Reflux Disease and Non-Erosive Reflux Disease, run by Nycomed at 1,153 sites in Germany.
Trial summary
The aim of the study was to evaluate the effect of Pantoprazole 20 mg/40 mg for 14 days on symptoms in patients with NERD (non-erosive reflux disease) or eGERD (erosive gastroesophageal reflux disease) with special focus on the reduction of symptomatic sleep disorders. Read more about this study
- Who is it for?
- Ages 12 years and older
- Conditions the study is for
- Erosive Gastroesophageal Reflux Disease, Non-Erosive Reflux Disease
- What is being tested?
- Pantoprazole
- How many people
- 8,616 participants
- Where
- 1,153 sitesGermany
- Study dates
- Oct 2007to Apr 2009
- Phase
- Observational
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Outpatients
Main inclusion criteria:
- GERD
- NERD
Main exclusion criteria:
- Criteria as defined in the Summary of Product Characteristics
Trial locations and contacts
1,153 sites in 1 country.
300 sites in 1 country
Germany300 sites
Nycomed Deutschland GmbH
Aachen, 52072
Nycomed Deutschland GmbH
Aachen, 52078
Nycomed Deutschland GmbH
Aalen, 73433
Nycomed Deutschland GmbH
Achern, 77855
Nycomed Deutschland GmbH
Achim, 28832
Nycomed Deutschland GmbH
Adenau, 53518
Nycomed Deutschland GmbH
Adorf, 08626
Nycomed Deutschland GmbH
Ahrensburg, 22926
Nycomed Deutschland GmbH
Aicha, 94529
Nycomed Deutschland GmbH
Albstadt, 72459
Nycomed Deutschland GmbH
Alfhausen, 49594
Nycomed Deutschland GmbH
Alpen, 46519
Nycomed Deutschland GmbH
Alpenrod, 57642
Nycomed Deutschland GmbH
Altenburg, 04600
Nycomed Deutschland GmbH
Altenholz, 24161
Nycomed Deutschland GmbH
Altenkirchen, 66903
Nycomed Deutschland GmbH
Alzenau in Unterfranken, 63755
Nycomed Deutschland GmbH
Alzey, 55232
Nycomed Deutschland GmbH
Amberg, 92224
Nycomed Deutschland GmbH
Angermünde, 16278
Nycomed Deutschland GmbH
Anklam, 17389
Nycomed Deutschland GmbH
Annaberg-Buchholz, 09456
Nycomed Deutschland GmbH
Annweiler am Trifels, 76855
Nycomed Deutschland GmbH
Apolda, 99510
Nycomed Deutschland GmbH
Arnsberg, 59755
Nycomed Deutschland GmbH
Arnsdorf, 01477
Nycomed Deutschland GmbH
Ascheberg, 24326
Nycomed Deutschland GmbH
Aschendorf, 26871
Nycomed Deutschland GmbH
Aschersleben, 06449
Nycomed Deutschland GmbH
Attenkirchen, 85395
Nycomed Deutschland GmbH
Aue, 08280
Nycomed Deutschland GmbH
Auerbach, 08209
Nycomed Deutschland GmbH
Augsburg, 86150
Nycomed Deutschland GmbH
Augsburg, 86153
Nycomed Deutschland GmbH
Augsburg, 86159
Nycomed Deutschland GmbH
Augsburg, 86161
Nycomed Deutschland GmbH
Augsburg, 86163
Nycomed Deutschland GmbH
Augsburg, 86167
Nycomed Deutschland GmbH
Augustusburg, 09573
Nycomed Deutschland GmbH
Aumühle, 21521
Nycomed Deutschland GmbH
Babenhausen, 64832
Nycomed Deutschland GmbH
Bad Aibling, 83043
Nycomed Deutschland GmbH
Bad Bederkesa, 27624
Nycomed Deutschland GmbH
Bad Berka, 99438
Nycomed Deutschland GmbH
Bad Bevensen, 29549
Nycomed Deutschland GmbH
Bad Bramstedt, 24576
Nycomed Deutschland GmbH
Bad Buchau, 88422
Nycomed Deutschland GmbH
Bad Doberan, 18209
Nycomed Deutschland GmbH
Bad Dürkheim, 67098
Nycomed Deutschland GmbH
Bad Dürrheim, 78073
Nycomed Deutschland GmbH
Bad Essen, 49152
Nycomed Deutschland GmbH
Bad Fallingbostel, 29683
Nycomed Deutschland GmbH
Bad Klosterlausnitz, 07639
Nycomed Deutschland GmbH
Bad Kreuznach, 55545
Nycomed Deutschland GmbH
Bad Krozingen, 79189
Nycomed Deutschland GmbH
Bad Langensalza, 99947
Nycomed Deutschland GmbH
Bad Lauterberg im Harz, 37431
Nycomed Deutschland GmbH
Bad Liebenwerda, 04924
Nycomed Deutschland GmbH
Bad Lippspringe, 33175
Nycomed Deutschland GmbH
Bad Nauheim, 61231
Nycomed Deutschland GmbH
Bad Neustadt an der Saale, 97616
Nycomed Deutschland GmbH
Bad Oeynhausen, 32547
Nycomed Deutschland GmbH
Bad Oeynhausen, 32549
Nycomed Deutschland GmbH
Bad Oldesloe, 23843
Nycomed Deutschland GmbH
Bad Salzuflen, 32105
Nycomed Deutschland GmbH
Bad Salzuflen, 32108
Nycomed Deutschland GmbH
Bad Sassendorf, 59505
Nycomed Deutschland GmbH
Bad Schussenried, 88427
Nycomed Deutschland GmbH
Bad Suderode, 06507
Nycomed Deutschland GmbH
Bad Tölz, 83646
Nycomed Deutschland GmbH
Bad Vilbel, 61118
Nycomed Deutschland GmbH
Bad Waldsee, 88339
Nycomed Deutschland GmbH
Bad Windsheim, 91438
Nycomed Deutschland GmbH
Baden-Baden, 76530
Nycomed Deutschland GmbH
Bahrdorf, 38459
Nycomed Deutschland GmbH
Bakum, 49456
Nycomed Deutschland GmbH
Balingen, 72336
Nycomed Deutschland GmbH
Ballenstedt, 06493
Nycomed Deutschland GmbH
Bamberg, 96047
Nycomed Deutschland GmbH
Bammental, 69245
Nycomed Deutschland GmbH
Barmstedt, 25355
Nycomed Deutschland GmbH
Bausendorf, 54538
Nycomed Deutschland GmbH
Bautzen, 02625
Nycomed Deutschland GmbH
Bechhofen, 66894
Nycomed Deutschland GmbH
Beeskow, 15848
Nycomed Deutschland GmbH
Bergisch Gladbach, 51429
Nycomed Deutschland GmbH
Bergisch Gladbach, 51465
Nycomed Deutschland GmbH
Bergkamen, 59192
Nycomed Deutschland GmbH
Bergtheim, 97241
Nycomed Deutschland GmbH
Berlin, 10117
Nycomed Deutschland GmbH
Berlin, 10119
Nycomed Deutschland GmbH
Berlin, 10243
Nycomed Deutschland GmbH
Berlin, 10245
Nycomed Deutschland GmbH
Berlin, 10247
Nycomed Deutschland GmbH
Berlin, 10315
Nycomed Deutschland GmbH
Berlin, 10317
Nycomed Deutschland GmbH
Berlin, 10318
Nycomed Deutschland GmbH
Berlin, 10319
Nycomed Deutschland GmbH
Berlin, 10367
Nycomed Deutschland GmbH
Berlin, 10369
Nycomed Deutschland GmbH
Berlin, 10409
Nycomed Deutschland GmbH
Berlin, 10557
Nycomed Deutschland GmbH
Berlin, 10623
Nycomed Deutschland GmbH
Berlin, 10627
Nycomed Deutschland GmbH
Berlin, 10713
Nycomed Deutschland GmbH
Berlin, 10715
Nycomed Deutschland GmbH
Berlin, 10777
Nycomed Deutschland GmbH
Berlin, 10781
Nycomed Deutschland GmbH
Berlin, 10967
Nycomed Deutschland GmbH
Berlin, 10999
Nycomed Deutschland GmbH
Berlin, 12043
Nycomed Deutschland GmbH
Berlin, 12051
Nycomed Deutschland GmbH
Berlin, 12055
Nycomed Deutschland GmbH
Berlin, 12057
Nycomed Deutschland GmbH
Berlin, 12101
Nycomed Deutschland GmbH
Berlin, 12347
Nycomed Deutschland GmbH
Berlin, 12351
Nycomed Deutschland GmbH
Berlin, 12439
Nycomed Deutschland GmbH
Berlin, 12459
Nycomed Deutschland GmbH
Berlin, 12487
Nycomed Deutschland GmbH
Berlin, 12489
Nycomed Deutschland GmbH
Berlin, 12524
Nycomed Deutschland GmbH
Berlin, 12555
Nycomed Deutschland GmbH
Berlin, 12559
Nycomed Deutschland GmbH
Berlin, 12619
Nycomed Deutschland GmbH
Berlin, 12621
Nycomed Deutschland GmbH
Berlin, 12627
Nycomed Deutschland GmbH
Berlin, 12683
Nycomed Deutschland GmbH
Berlin, 12689
Nycomed Deutschland GmbH
Berlin, 13051
Nycomed Deutschland GmbH
Berlin, 13055
Nycomed Deutschland GmbH
Berlin, 13086
Nycomed Deutschland GmbH
Berlin, 13125
Nycomed Deutschland GmbH
Berlin, 13156
Nycomed Deutschland GmbH
Berlin, 13158
Nycomed Deutschland GmbH
Berlin, 13187
Nycomed Deutschland GmbH
Berlin, 13347
Nycomed Deutschland GmbH
Berlin, 13353
Nycomed Deutschland GmbH
Berlin, 13355
Nycomed Deutschland GmbH
Berlin, 13357
Nycomed Deutschland GmbH
Berlin, 13359
Nycomed Deutschland GmbH
Berlin, 13409
Nycomed Deutschland GmbH
Berlin, 13507
Nycomed Deutschland GmbH
Berlin, 13581
Nycomed Deutschland GmbH
Berlin, 13583
Nycomed Deutschland GmbH
Berlin, 13595
Nycomed Deutschland GmbH
Berlin, 13597
Nycomed Deutschland GmbH
Berlin, 14050
Nycomed Deutschland GmbH
Berlin, 14052
Nycomed Deutschland GmbH
Berlin, 14089
Nycomed Deutschland GmbH
Berlin, 14193
Nycomed Deutschland GmbH
Bernburg, 06406
Nycomed Deutschland GmbH
Berne, 27804
Nycomed Deutschland GmbH
Bernkastel-Kues, 54470
Nycomed Deutschland GmbH
Beucha, 04824
Nycomed Deutschland GmbH
Beverungen, 37688
Nycomed Deutschland GmbH
Biberach, 88400
Nycomed Deutschland GmbH
Bielefeld, 33602
Nycomed Deutschland GmbH
Bielefeld, 33739
Nycomed Deutschland GmbH
Bietigheim-Bissingen, 74321
Nycomed Deutschland GmbH
Birkenfeld, 97834
Nycomed Deutschland GmbH
Birkenwerder, 16547
Nycomed Deutschland GmbH
Bischofswerda, 01877
Nycomed Deutschland GmbH
Bitburg, 54634
Nycomed Deutschland GmbH
Blankenhain, 99444
Nycomed Deutschland GmbH
Blaustein, 89134
Nycomed Deutschland GmbH
Bochum, 44787
Nycomed Deutschland GmbH
Bochum, 44789
Nycomed Deutschland GmbH
Bochum, 44791
Nycomed Deutschland GmbH
Bochum, 44795
Nycomed Deutschland GmbH
Bochum, 44807
Nycomed Deutschland GmbH
Bochum, 44866
Nycomed Deutschland GmbH
Bodman-Ludwigshafen, 78351
Nycomed Deutschland GmbH
Bohmte, 49163
Nycomed Deutschland GmbH
Bonn, 53121
Nycomed Deutschland GmbH
Bonn, 53179
Nycomed Deutschland GmbH
Bonndorf, 79848
Nycomed Deutschland GmbH
Borna, 04552
Nycomed Deutschland GmbH
Börnsen, 21039
Nycomed Deutschland GmbH
Bottendorf, 06571
Nycomed Deutschland GmbH
Bottrop, 46240
Nycomed Deutschland GmbH
Bovenden, 37120
Nycomed Deutschland GmbH
Brake, 26919
Nycomed Deutschland GmbH
Brakel, 33034
Nycomed Deutschland GmbH
Bramsche, 49565
Nycomed Deutschland GmbH
Brand-Erbisdorf, 09618
Nycomed Deutschland GmbH
Braunsbedra, 06242
Nycomed Deutschland GmbH
Braunschweig, 38106
Nycomed Deutschland GmbH
Braunschweig, 38112
Nycomed Deutschland GmbH
Braunschweig, 38120
Nycomed Deutschland GmbH
Bredstedt, 25821
Nycomed Deutschland GmbH
Breidenbach, 35236
Nycomed Deutschland GmbH
Breitenfelde, 23881
Nycomed Deutschland GmbH
Bremen, 28327
Nycomed Deutschland GmbH
Bremen, 28717
Nycomed Deutschland GmbH
Bremen, 28755
Nycomed Deutschland GmbH
Bremerhaven, 27568
Nycomed Deutschland GmbH
Bremerhaven, 27570
Nycomed Deutschland GmbH
Bremerhaven, 27580
Nycomed Deutschland GmbH
Bretten, 75015
Nycomed Deutschland GmbH
Brilon, 59929
Nycomed Deutschland GmbH
Bröckel, 29356
Nycomed Deutschland GmbH
Brüel, 19412
Nycomed Deutschland GmbH
Brühl, 50321
Nycomed Deutschland GmbH
Büchen, 21514
Nycomed Deutschland GmbH
Büchenbach, 91186
Nycomed Deutschland GmbH
Buchloe, 86807
Nycomed Deutschland GmbH
Buckow, 15377
Nycomed Deutschland GmbH
Bühlertann, 74424
Nycomed Deutschland GmbH
Burg, 39288
Nycomed Deutschland GmbH
Burgbrohl, 56659
Nycomed Deutschland GmbH
Burgdorf, Hanover, 31303
Nycomed Deutschland GmbH
Burgsinn, 97775
Nycomed Deutschland GmbH
Burgstädt, 09217
Nycomed Deutschland GmbH
Burkardroth, 97705
Nycomed Deutschland GmbH
Burladingen, 72393
Nycomed Deutschland GmbH
Butzbach, 35510
Nycomed Deutschland GmbH
Castrop-Rauxel, 44575
Nycomed Deutschland GmbH
Celle, 29221
Nycomed Deutschland GmbH
Celle, 29223
Nycomed Deutschland GmbH
Celle, 29229
Nycomed Deutschland GmbH
Chemnitz, 09111
Nycomed Deutschland GmbH
Chemnitz, 09116
Nycomed Deutschland GmbH
Chemnitz, 09119
Nycomed Deutschland GmbH
Chemnitz, 09122
Nycomed Deutschland GmbH
Chemnitz, 09123
Nycomed Deutschland GmbH
Chemnitz, 09126
Nycomed Deutschland GmbH
Chemnitz, 09127
Nycomed Deutschland GmbH
Claußnitz, 09236
Nycomed Deutschland GmbH
Clausthal-Zellerfeld, 38678
Nycomed Deutschland GmbH
Cochem, 56812
Nycomed Deutschland GmbH
Coesfeld, 48653
Nycomed Deutschland GmbH
Cologne, 50670
Nycomed Deutschland GmbH
Cologne, 50733
Nycomed Deutschland GmbH
Cologne, 50825
Nycomed Deutschland GmbH
Cologne, 50999
Nycomed Deutschland GmbH
Cologne, 51063
Nycomed Deutschland GmbH
Cologne, 51065
Nycomed Deutschland GmbH
Cologne, 51069
Nycomed Deutschland GmbH
Cologne, 51103
Nycomed Deutschland GmbH
Cologne, 51149
Nycomed Deutschland GmbH
Coswig, 01640
Nycomed Deutschland GmbH
Cottbus, 03048
Nycomed Deutschland GmbH
Cottbus, 03050
Nycomed Deutschland GmbH
Crimmitschau, 08451
Nycomed Deutschland GmbH
Crostwitz, 01920
Nycomed Deutschland GmbH
Cuxhaven, 27478
Nycomed Deutschland GmbH
Dachau, 85221
Nycomed Deutschland GmbH
Dargun, 17159
Nycomed Deutschland GmbH
Darmstadt, 64233
Nycomed Deutschland GmbH
Deggingen, 73326
Nycomed Deutschland GmbH
Deidesheim, 67146
Nycomed Deutschland GmbH
Delitzsch, 04509
Nycomed Deutschland GmbH
Denkendorf, 73770
Nycomed Deutschland GmbH
Denzlingen, 79211
Nycomed Deutschland GmbH
Dessau, 06844
Nycomed Deutschland GmbH
Dessau, 06847
Nycomed Deutschland GmbH
Dessau, 06849
Nycomed Deutschland GmbH
Detmold, 32756
Nycomed Deutschland GmbH
Dettmannsdorf, 18334
Nycomed Deutschland GmbH
Diepholz, 49356
Nycomed Deutschland GmbH
Dierdorf, 56269
Nycomed Deutschland GmbH
Dillingen, 66763
Nycomed Deutschland GmbH
Dillingen-Diefflen, 66763
Nycomed Deutschland GmbH
Dingolfing, 84130
Nycomed Deutschland GmbH
Dinkelsbühl, 91550
Nycomed Deutschland GmbH
Dinkelscherben, 86424
Nycomed Deutschland GmbH
Dinslaken, 46535
Nycomed Deutschland GmbH
Dinslaken, 46539
Nycomed Deutschland GmbH
Döbeln, 04720
Nycomed Deutschland GmbH
Doberschütz, 04838
Nycomed Deutschland GmbH
Donaueschingen, 78166
Nycomed Deutschland GmbH
Dörentrup, 32694
Nycomed Deutschland GmbH
Dörpen, 26892
Nycomed Deutschland GmbH
Dorsten, 46282
Nycomed Deutschland GmbH
Dortmund, 44269
Nycomed Deutschland GmbH
Dortmund, 44388
Nycomed Deutschland GmbH
Dörzbach, 74677
Nycomed Deutschland GmbH
Dresden, 01067
Nycomed Deutschland GmbH
Dresden, 01069
Nycomed Deutschland GmbH
Dresden, 01099
Nycomed Deutschland GmbH
Dresden, 01108
Nycomed Deutschland GmbH
Dresden, 01109
Nycomed Deutschland GmbH
Dresden, 01127
Nycomed Deutschland GmbH
Dresden, 01129
Nycomed Deutschland GmbH
Dresden, 01139
Nycomed Deutschland GmbH
Dresden, 01157
Nycomed Deutschland GmbH
Dresden, 01159
Nycomed Deutschland GmbH
Dresden, 01187
Nycomed Deutschland GmbH
Dresden, 01239
Nycomed Deutschland GmbH
Dresden, 01257
Nycomed Deutschland GmbH
Dresden, 01259
Nycomed Deutschland GmbH
Dresden, 01277
Nycomed Deutschland GmbH
Dresden, 01279
Nycomed Deutschland GmbH
Dresden, 01307
Nycomed Deutschland GmbH
Dresden, 01309
Nycomed Deutschland GmbH
Dresden, 01324
Nycomed Deutschland GmbH
Dresden-Cossebaude, 01156
Nycomed Deutschland GmbH
Dudenhofen, 67373
Nycomed Deutschland GmbH
Duderstadt, 37115
About this study
Official title: Pantoprazole for the Treatment of GERD Associated Symptoms Focusing on Sleep Disorders.
The aim of the study was to evaluate the effect of Pantoprazole 20 mg/40 mg for 14 days on symptoms in patients with NERD (non-erosive reflux disease) or eGERD (erosive gastroesophageal reflux disease) with special focus on the reduction of symptomatic sleep disorders.
- Being tested
- Pantoprazole
- Keywords
- Pantoprazole, eGERD (Erosive Gastroesophageal Reflux Disease), NERD (Non-Erosive Reflux Disease), sleep disorders
- Medical subject headings
- Non-Erosive Reflux Disease, Sleep Wake Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PantoprazoleDrug
This was an observational study. Therefore, the physician decided about dosage according to individual needs.
| Study group | Role | What they receive |
|---|---|---|
| Pantoprazole | Not described Receives: Drug: Pantoprazole |
What is being measured
The primary outcome is the main question the study is designed to answer.
Assessment of the Severity of Sleep Disturbances
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Measured: first and last visit (after a median of 18 days)
Assessment of Change of Quality of Sleep During Therapy With Pantoprazole
Physician's assessment on a scale with
- considerably improved
- improved
- unchanged
Measured: last visit (after a median of 18 days)
Secondary outcomes (6)
Assessment of the Severity of Heartburn
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Measured: first and last visit (after a median of 18 days)
Assessment of the Severity of Eructation/Acid Eructation
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Measured: first and last visit (after a median of 18 days)
Assessment of the Severity of Epigastric Complaints/Epigastric Pain
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Measured: first and last visit (after a median of 18 days)
Assessment of the Severity of Sensation of Fullness/Abdominal Distension
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Measured: first and last visit (after a median of 18 days)
Assessment of the Efficacy of Pantoprazole at Final Visit
Physician's assessment on a scale with 1=excellent, 2=good, 3=satisfactory, 4=not satisfactory
Measured: last visit (after a median of 18 days)
Assessment of the Tolerability of Pantoprazole at Final Visit
Physician's assessment on a scale with 1=excellent, 2=good, 3=satisfactory, 4=not satisfactory
Measured: last visit (after a median of 18 days)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Nov 2007 (estimated)
- Study startOct 2007
- Primary completionApr 2009
- Study completionApr 2009
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Erosive Gastroesophageal Reflux DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 8,616 participants (actual)
Sponsor and investigators
- Lead sponsor
- Nycomed
- Sponsor type
- Industry (pharma, biotech, devices)
- Investigators
- Dr. Thomas D. Bethke, MD, MBA, Study director, Nycomed Deutschland GmbH, 78467 Konstanz, Germany
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00562094
- Sponsor's protocol ID
- PAN 20/40 PULS 07/10
- Acronym
- PULS
- Status last verified
- May 2012
- First submitted
- 12 Nov 2007
- Last updated
- 8 May 2012
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 May 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Pantoprazole for the Treatment of GERD Associated Symptoms Focusing on Sleep Disorders.
- ClinicalTrials.gov ID
- NCT00562094
- Acronym / sponsor ID
- PULS / PAN 20/40 PULS 07/10
- Keywords
- Pantoprazole, eGERD (Erosive Gastroesophageal Reflux Disease), NERD (Non-Erosive Reflux Disease), sleep disorders
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 8,616 participants (actual)
- Lead sponsor
- NycomedIndustry (pharma, biotech, devices)
- Study start
- Oct 2007
- Primary completion
- Apr 2009 (actual)
- Study completion
- Apr 2009 (actual)
- First posted
- 21 Nov 2007 (estimated)
- Results
- Posted 24 Sep 2010
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of the study was to evaluate the effect of Pantoprazole 20 mg/40 mg for 14 days on symptoms in patients with NERD (non-erosive reflux disease) or eGERD (erosive gastroesophageal reflux disease) with special focus on the reduction of symptomatic sleep disorders.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Pantoprazole | – | Drug: Pantoprazole |
Who may qualify
- Ages
- 12 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Outpatients
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PantoprazoleThis was an observational study. Therefore, the physician decided about dosage according to individual needs. | Drug | Pantoprazole |
Primary outcome
Assessment of the Severity of Sleep Disturbances
Time frame: first and last visit (after a median of 18 days)
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Assessment of Change of Quality of Sleep During Therapy With Pantoprazole
Time frame: last visit (after a median of 18 days)
Physician's assessment on a scale with * considerably improved * improved * unchanged
6 secondary outcomes
Assessment of the Severity of Heartburn
Time frame: first and last visit (after a median of 18 days)
Assessment of the Severity of Eructation/Acid Eructation
Time frame: first and last visit (after a median of 18 days)
Assessment of the Severity of Epigastric Complaints/Epigastric Pain
Time frame: first and last visit (after a median of 18 days)
Assessment of the Severity of Sensation of Fullness/Abdominal Distension
Time frame: first and last visit (after a median of 18 days)
Assessment of the Efficacy of Pantoprazole at Final Visit
Time frame: last visit (after a median of 18 days)
Assessment of the Tolerability of Pantoprazole at Final Visit
Time frame: last visit (after a median of 18 days)
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 May 2012.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Related trials for Erosive Gastroesophageal Reflux Disease
RecruitingObservational study
Post-Marketing Surveillance to Evaluate the Safety and Effectiveness of Zastaprazan Citrate
Erosive Gastroesophageal Reflux Disease
RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Vonoprazan 10 mg Compared to Placebo for Relief of Episodic Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease Through 24 Weeks
Symptomatic Non-erosive Gastroesophageal Reflux Disease
Not yet recruitingPhase 4
PPI Dosing Per CYP2C19 Genotype
Gastroesophageal Reflux Disease With Esophagitis
RecruitingObservational study
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
Erosive Esophagitis, Heartburn
Recruiting
Neuroregulators for the Treatment of Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities.
Gut-Brain Disorders, GERD Without Erosive Esophagitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Dr. Thomas D. Bethke, MD, MBA study director
Nycomed Deutschland GmbH, 78467 Konstanz, Germany
1,153 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Erosive Gastroesophageal Reflux Disease and Non-Erosive Reflux Disease, run by Nycomed at 1,153 sites in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 May 2012. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1,153 sites in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 24 Sep 2010). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Assessment of the Severity of Sleep Disturbances (time frame: first and last visit (after a median of 18 days)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2012.